Cargando…

Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia

Lung damage in coronavirus disease 2019 (COVID-19) pneumonia may be so severe that management with lung-protective ventilation, neuromuscular blockade, and proning cannot sustain life. Extracorporeal membrane oxygenation (ECMO) may allow patients with acute respiratory distress syndrome (ARDS) to un...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Taha, Barakat, Mark, Baptiste, Trevaughn R, Hasan, Mahera, Engdahl, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785490/
https://www.ncbi.nlm.nih.gov/pubmed/33425518
http://dx.doi.org/10.7759/cureus.11938
_version_ 1783632455973994496
author Mallick, Taha
Barakat, Mark
Baptiste, Trevaughn R
Hasan, Mahera
Engdahl, Ryan
author_facet Mallick, Taha
Barakat, Mark
Baptiste, Trevaughn R
Hasan, Mahera
Engdahl, Ryan
author_sort Mallick, Taha
collection PubMed
description Lung damage in coronavirus disease 2019 (COVID-19) pneumonia may be so severe that management with lung-protective ventilation, neuromuscular blockade, and proning cannot sustain life. Extracorporeal membrane oxygenation (ECMO) may allow patients with acute respiratory distress syndrome (ARDS) to undergo a period of lung recovery before being transitioned back to mechanical ventilation. A successful outcome requires both timely initiation of ECMO before development of irreversible organ injury from severe ARDS and selection of patients with adequate physiologic reserve. We present a 40-year-old healthy male patient with severe COVID-19 pneumonia not responsive to more conservative options for ARDS management. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) rescue therapy was instituted and after 34 days he was successfully decannulated and eventually discharged from the hospital in good condition. Despite needing ECMO for longer than what is reported in most case reports and series involving patients with COVID-19 pneumonia, our patient made a complete recovery. He was also followed up in an outpatient setting and seen to be doing well. With appropriate patient selection and timely initiation of ECMO, many patients stand to benefit from this treatment. Ensuring that therapy be delivered to these patients when the need arises requires meticulous planning and provision of the appropriate resources. In addition, inflammatory markers may serve as a further guide to decision-making in patients already on ECMO as has already been indicated in the literature.
format Online
Article
Text
id pubmed-7785490
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-77854902021-01-07 Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia Mallick, Taha Barakat, Mark Baptiste, Trevaughn R Hasan, Mahera Engdahl, Ryan Cureus Infectious Disease Lung damage in coronavirus disease 2019 (COVID-19) pneumonia may be so severe that management with lung-protective ventilation, neuromuscular blockade, and proning cannot sustain life. Extracorporeal membrane oxygenation (ECMO) may allow patients with acute respiratory distress syndrome (ARDS) to undergo a period of lung recovery before being transitioned back to mechanical ventilation. A successful outcome requires both timely initiation of ECMO before development of irreversible organ injury from severe ARDS and selection of patients with adequate physiologic reserve. We present a 40-year-old healthy male patient with severe COVID-19 pneumonia not responsive to more conservative options for ARDS management. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) rescue therapy was instituted and after 34 days he was successfully decannulated and eventually discharged from the hospital in good condition. Despite needing ECMO for longer than what is reported in most case reports and series involving patients with COVID-19 pneumonia, our patient made a complete recovery. He was also followed up in an outpatient setting and seen to be doing well. With appropriate patient selection and timely initiation of ECMO, many patients stand to benefit from this treatment. Ensuring that therapy be delivered to these patients when the need arises requires meticulous planning and provision of the appropriate resources. In addition, inflammatory markers may serve as a further guide to decision-making in patients already on ECMO as has already been indicated in the literature. Cureus 2020-12-06 /pmc/articles/PMC7785490/ /pubmed/33425518 http://dx.doi.org/10.7759/cureus.11938 Text en Copyright © 2020, Mallick et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Infectious Disease
Mallick, Taha
Barakat, Mark
Baptiste, Trevaughn R
Hasan, Mahera
Engdahl, Ryan
Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title_full Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title_fullStr Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title_full_unstemmed Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title_short Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia
title_sort successful use of veno-venous extracorporeal membrane oxygenation in a patient with severe covid-19 pneumonia
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785490/
https://www.ncbi.nlm.nih.gov/pubmed/33425518
http://dx.doi.org/10.7759/cureus.11938
work_keys_str_mv AT mallicktaha successfuluseofvenovenousextracorporealmembraneoxygenationinapatientwithseverecovid19pneumonia
AT barakatmark successfuluseofvenovenousextracorporealmembraneoxygenationinapatientwithseverecovid19pneumonia
AT baptistetrevaughnr successfuluseofvenovenousextracorporealmembraneoxygenationinapatientwithseverecovid19pneumonia
AT hasanmahera successfuluseofvenovenousextracorporealmembraneoxygenationinapatientwithseverecovid19pneumonia
AT engdahlryan successfuluseofvenovenousextracorporealmembraneoxygenationinapatientwithseverecovid19pneumonia